Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curt I Civin

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Stem Cells (Dayton, Ohio)|November 29, 2002
Commitment to biomedical research: clearing unnecessary impediments to progressCurt I Civin
Stem Cells (Dayton, Ohio)|May 12, 2006
Troublesome questionsCurt I Civin
Transfusion|June 22, 2010
CD34 stem cell stories and lessons from the CD34 wars: the Landsteiner Lecture 2009Curt I Civin
Stem Cells (Dayton, Ohio)|May 22, 2004
Two steps forward: keeping the momentum in stem cell researchJamie Palaganas, Curt I Civin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity?Osnat Bohana-Kashtan, Curt I Civin
Stem Cells (Dayton, Ohio)|November 19, 2005
Translational research: toward better characterization of human embryonic stem cell linesMahendra S Rao, Curt I Civin
Stem Cells (Dayton, Ohio)|March 18, 2006
How many human embryonic stem cell lines are sufficient? A U.S. perspectiveCurt I Civin, Mahendra S Rao
Stem Cells (Dayton, Ohio)|November 13, 2004
Fas ligand as a tool for immunosuppression and generation of immune toleranceOsnat Bohana-Kashtan, Curt I Civin
Cancer Biology & Therapy|August 25, 2004
Digital HLA allelotypingOzlem Topaloglu, Curt I Civin, Fred Bunz
Advances in Cancer Research|January 30, 2019
Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH networkTami J Kingsbury, MinJung Kim, Curt I Civin
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Stem Cells (Dayton, Ohio)|November 29, 2002
Commitment to biomedical research: clearing unnecessary impediments to progressCurt I Civin
Stem Cells (Dayton, Ohio)|May 12, 2006
Troublesome questionsCurt I Civin
Transfusion|June 22, 2010
CD34 stem cell stories and lessons from the CD34 wars: the Landsteiner Lecture 2009Curt I Civin
Stem Cells (Dayton, Ohio)|May 22, 2004
Two steps forward: keeping the momentum in stem cell researchJamie Palaganas, Curt I Civin
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity?Osnat Bohana-Kashtan, Curt I Civin
Stem Cells (Dayton, Ohio)|November 19, 2005
Translational research: toward better characterization of human embryonic stem cell linesMahendra S Rao, Curt I Civin
Stem Cells (Dayton, Ohio)|March 18, 2006
How many human embryonic stem cell lines are sufficient? A U.S. perspectiveCurt I Civin, Mahendra S Rao
Stem Cells (Dayton, Ohio)|November 13, 2004
Fas ligand as a tool for immunosuppression and generation of immune toleranceOsnat Bohana-Kashtan, Curt I Civin
Cancer Biology & Therapy|August 25, 2004
Digital HLA allelotypingOzlem Topaloglu, Curt I Civin, Fred Bunz
Advances in Cancer Research|January 30, 2019
Regulation of cancer stem cell properties by SIX1, a member of the PAX-SIX-EYA-DACH networkTami J Kingsbury, MinJung Kim, Curt I Civin
Pageof 7